196 related articles for article (PubMed ID: 11120049)
1. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation.
Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S
Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049
[No Abstract] [Full Text] [Related]
2. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting.
Kita Y; Li XK; Funeshima N; Enosawa S; Tamura A; Hayashi S; Suzuki K; Kazui T; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2787-8. PubMed ID: 10578291
[No Abstract] [Full Text] [Related]
3. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
Xu M; Antoniou EA; Afford SC; Suzuki S; Pirenne J; McMaster P; D'Silva M
Transplant Proc; 1997 Nov; 29(7):2964-6. PubMed ID: 9365631
[No Abstract] [Full Text] [Related]
4. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2.
Arima T; Rehman A; Flye MW
Transplant Proc; 1997; 29(1-2):1305-6. PubMed ID: 9123318
[No Abstract] [Full Text] [Related]
5. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
Matsumoto Y; Hof RP
Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
[No Abstract] [Full Text] [Related]
6. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
[No Abstract] [Full Text] [Related]
7. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.
Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420
[No Abstract] [Full Text] [Related]
8. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation.
Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P
Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447
[No Abstract] [Full Text] [Related]
9. Prolongation of concordant xenograft survival by treatment with FTY720.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
[No Abstract] [Full Text] [Related]
10. Gene gun-mediated CTLA4Ig-gene transfer for modification of allogeneic cardiac grafts.
Umeda Y; Iwata H; Yoshikawa S; Matsuno Y; Marui T; Nitta T; Idia Y; Takagi H; Mori Y; Miyazaki J; Kosugi A; Hirose H
Transplant Proc; 2002 Nov; 34(7):2622-3. PubMed ID: 12431548
[No Abstract] [Full Text] [Related]
11. Long-term graft acceptance in rat heart transplantation by CTLA4Ig gene transfection combined with FTY720 treatment.
Ohba M; Li XK; Kita Y; Enosawa S; Funeshima N; Nagai H; Zhang H; Okuyama T; Ogoshi S; Sasaguri S; Amemiya H; Suzuki S
World J Surg; 2001 Apr; 25(4):391-7; discussion 397-8. PubMed ID: 11344387
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of CTLA4IG gene results in prolonged survival of heart allograft.
Guang-Lin M; Hayashi S; Yokoyama I; Namii Y; Kobayashi T; Katayama A; Nagasaka T; Hamada H; Negita M; Takagi H
Transplant Proc; 1998 Nov; 30(7):2923-4. PubMed ID: 9838288
[No Abstract] [Full Text] [Related]
13. Rescuing acute rejection of rat cardiac allografts with FTY720.
Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
[No Abstract] [Full Text] [Related]
14. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
[No Abstract] [Full Text] [Related]
15. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.
Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S
Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526
[No Abstract] [Full Text] [Related]
16. CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas.
Kita Y; Li XK; Nogimura H; Ida M; Kageyama Y; Ohi S; Suzuki K; Kazui T; Suzuki S
Transplant Proc; 2003 Feb; 35(1):458-60. PubMed ID: 12591486
[No Abstract] [Full Text] [Related]
17. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.
Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K
Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547
[No Abstract] [Full Text] [Related]
18. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
20. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
